MHMonash Hub

Units / MPS5102

MPS5102 · Target identification and validation

Official Handbook

2026 Handbook6 credit pointsLevel 5Faculty of Pharmacy and Pharmaceutical Sciences

Last checked: 23 Aug 2026 UTC

Overview

This unit outlines the relationship between pathophysiology and the rational design and use of drugs. You will be introduced to the physiological basis of disease, highlighting the causal connections between cell biochemistry, body function at the tissue, organ and system level, and human health. You will study the relationship between ligands (endogenous and exogenous) and the activation of specific cellular responses, and will explain how the selection of a relevant therapeutic target is based on a thorough understanding of biochemistry, physiology and pharmacology, and the impact of the disease process on optimal function. Upon completing this unit, you will understand how aberrant signalling may be modified through identification and validation of appropriate protein, lipid or DNA targets, and be prepared to take these targets to the next stage in the process: drug design and optimisation.

Offerings

CampusTeaching periodMode
ParkvilleFirst semesterTeaching activities are on-campus (ON-CAMPUS)
MalaysiaFirst semesterTeaching activities are on-campus (ON-CAMPUS)

Assessment

The Handbook lists an examination for this unit.

#AssessmentTypeWeightHurdle
1Disease and drug dossiers Project50%
2Final recap and reflection Written15%
3Oral examinations – vivas Demonstration35%

Assessment details may change. Please refer to the assessment information in Moodle closer to the start of the teaching period.

Requisites

The Handbook lists no prerequisite, corequisite or prohibition for this unit.

Learning outcomes

  1. Describe the processes by which disease states can alter homeostatic and physiological functions (pathophysiology), explaining the relationship between disrupted function/s and observed signs and symptoms
  2. Explain in detail how drug treatments target the pathophysiology disease states, identifying the drug target and cellular target relevant to the disease state
  3. Articulate the process of target identification and validation using selected disease states as case studies, and explain how emerging technologies are integrated into the process of target identification and validation and their advantages.
  4. Define the characteristics of an ideal drug target and use a systematic approach to evaluate whether exemplar therapeutics reflect these properties, proposing a rationale for why deviating from accepted drug target might be acceptable and/or necessary in certain situations
  5. Use effective teamwork and collaborative skills, and research skills to develop a set of target identification and validation dossiers
  6. Demonstrate oral and written communication skills appropriate for master’s students.

Workload

• 18 hours online modules (discovery) • Twelve 3-hour workshops • 55 hours of team-based collaborative work • 45 hours of independent study

ActivityDuration
Assessments12 hours
Workshops36 hours

Ask about MPS5102

Answered from the Handbook fields above — no AI, no guessing. Every answer links back to the source.

Community discussions about MPS5102

Community

Student experience, not official rules. Nothing here changes what the Handbook says.

No discussions yet

Be the first to share what this unit was actually like.

Monash HubAn independent student platform

Monash Hub is an independent student information platform and is not affiliated with or endorsed by Monash University. Always confirm enrolment, graduation, visa and academic policy decisions through the Monash website, Handbook, Moodle or WES.